$WOK

HRT FINANCIAL LP sold $188K of WOK

HRT FINANCIAL LP sold 1,757,955 shares of WORK Medical Technology Group LTD (WOK) at $0.11 ($0.19M total) on 2026-06-02.

Original reporting
SEC EDGAR · HRT FINANCIAL LP
Published Jun 3, 2026, 6:34 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 6:35 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$WOK
Bearish
medium confidence
Mentioned
$WOK
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$WOKBearishLow
01

Why it matters

The immediate tradable element is sentiment/positioning around WOK following the disclosed sale and the owner exiting the position.

02

Market read

For WOK, the key takeaway is the disclosed reduction to zero shares by a major owner at a low per-share price, which can affect near-term sentiment and liquidity expectations.

03

What to watch

No 10b5-1 plan is cited, but Form 4 filings often omit context; traders should check for other concurrent insider buys/sales or follow-on filings for confirmation.

Relevance 7/10Novelty 6/10Timing: after SEC Form 4 filing (filed 2026-06-03)

Background

The article is an SEC Form 4 insider transaction disclosure: a 10% owner sold shares in an open-market transaction.

Company-level read

Ticker impact

$WOKBearishMedium confidence
Context

HRT Financial LP (10% owner) filed an open-market sale of 1,757,955 WORK Medical Technology shares at $0.1070 on 2026-06-02.

Expected impact

Near-term downside bias or elevated volatility around the filing/next liquidity window; magnitude likely limited without additional company-specific news.

Evidence & confidence

The filing is a disclosed sale (not a buy) and the position is reduced to zero shares, but the article provides no stated reason (and no 10b5-1 plan), limiting causal inference.

Market effects

Limited sector read-through; this is company-specific ownership activity rather than a sector catalyst.

No clear regional spillover indicated by the filing alone.

Minimal global relevance; disclosure is localized to the issuer’s shareholder structure.

Counterpoint

The sale could be routine liquidity/portfolio rebalancing rather than a negative signal, especially given the large share count and lack of stated rationale.

Key entities

  • WORK Medical Technology Group LTD

    Subject of the Form 4 insider transaction; 10% owner sold shares.

  • HRT Financial LP

    Reporter of the open-market sale; holdings reduced to zero shares.

Related articles